Reshma Kewalramani
Vermögen: 21 Mio $ am 31.05.2026
Vermögen: 21 Mio $ am 31.05.2026
Reshma Kewalramani ist President, Chief Executive Officer & Director bei Vertex Pharmaceuticals, Inc. In der Vergangenheit war sie VP-Global Clinical Development & Nephrology bei Amgen, Inc. Sie erhielt einen Doktortitel von der Boston University School of Medicine.
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 16.03.2026 | 47 800 ( 0,02 % ) | 21 Mio $ | 31.05.2026 |
| Unternehmen | Position | Beginn |
|---|---|---|
| VERTEX PHARMACEUTICALS INCORPORATED | Vorstandsvorsitzender | 01.04.2020 |
| ALPINE IMMUNE SCIENCES, INC. | Präsident | 20.05.2024 |
Ginkgo Bioworks, Inc.
Ginkgo Bioworks, Inc. Information Technology ServicesTechnology Services Develops biological technology and software solutions | Direktor/Vorstandsmitglied | 03.08.2021 |
The General Hospital Corp.
The General Hospital Corp. Hospital/Nursing ManagementHealth Services Functions as a non profit organization that operates general hospital | Direktor/Vorstandsmitglied | - |
Biomedical Sciences Careers Program, Inc. | Direktor/Vorstandsmitglied | - |
Year Up, Inc.
Year Up, Inc. Miscellaneous Commercial ServicesCommercial Services Provides educational and professional development programs | Direktor/Vorstandsmitglied | 18.09.2023 |
| Unternehmen | Position | Ende |
|---|---|---|
| GINKGO BIOWORKS HOLDINGS, INC. | Direktor/Vorstandsmitglied | 13.06.2024 |
| AMGEN INC. | Corporate Officer/Principal | 01.01.2017 |
| GINO BIOW | Direktor/Vorstandsmitglied | - |
| ░░░░░░ ░░░░░░ ░░░░░░░░░░ | ░░░░░░░░░░░░░░░░░░░░░░░░░░ | - |
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
| Private Unternehmen | 12 |
|---|---|
Amgen, Inc.
Amgen, Inc. BiotechnologyHealth Technology Discovers, develops, manufactures and delivers human therapeutics | Health Technology |
Vertex Pharmaceuticals, Inc.
Vertex Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company that develops drugs for the treatment of cystic fibrosis | Health Technology |
Boston University
Boston University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The General Hospital Corp.
The General Hospital Corp. Hospital/Nursing ManagementHealth Services Functions as a non profit organization that operates general hospital | Health Services |
Biomedical Sciences Careers Program, Inc. | |
Year Up, Inc.
Year Up, Inc. Miscellaneous Commercial ServicesCommercial Services Provides educational and professional development programs | Commercial Services |
Boston University School of Medicine
Boston University School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Ginkgo Bioworks, Inc.
Ginkgo Bioworks, Inc. Information Technology ServicesTechnology Services Develops biological technology and software solutions | Technology Services |
Alpine Immune Sciences, Inc.
Alpine Immune Sciences, Inc. Pharmaceuticals: MajorHealth Technology Operates as an bio pharmaceutical company that develops immunotherapies for autoimmune and inflammatory diseases | Health Technology |
Kidney Health Initiative | |
Soaring Eagle Acquisition Corp.
Soaring Eagle Acquisition Corp. Financial ConglomeratesFinance Operates as a blank check company | Finance |
Ginkgo Bioworks Holdings, Inc.
Ginkgo Bioworks Holdings, Inc. Medical/Nursing ServicesHealth Services Develops biological engineering products and custom microbes | Health Services |
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen